Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Ľudmila Vodičková

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8277-539X; OpenAlex author ID A5037749737, A5110220747. Sources: OpenAlex.

Their work

Papers
19
Trials
0
Grants
0
Labs led
0
Collaborators
71
Papers, trials and grants by year

2013: 3 papers · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers

Papers 19

  1. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… Co-author DOI 10.1002/ijc.35196↗
  2. The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC. Co-author DOI 10.1016/j.semcancer.2025.05.004↗
  3. Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2025.05.005↗
  4. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. Co-author DOI 10.1186/s40246-024-00576-x↗
  5. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  6. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  7. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. Co-author DOI 10.1038/s41598-022-22973-9↗
  8. Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium. Co-author DOI 10.1158/1055-9965.epi-21-1340↗
  9. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/carcin/bgab057↗
  10. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction. Co-author DOI 10.1136/jmedgenet-2020-106961↗
  11. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
  12. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study. Co-author DOI 10.1002/ijc.31928↗
  13. Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.32127↗
  14. SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival. Co-author DOI 10.1038/srep43812↗
  15. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Co-author DOI 10.18632/oncotarget.10935↗
  16. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  17. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Co-author DOI 10.1016/j.dld.2012.09.014↗
  18. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Co-author DOI 10.1158/1055-9965.epi-12-1182↗
  19. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Co-author DOI 10.3892/or.2013.2285↗

Closest collaborators

The 25 strongest of 71 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pavel Vodička · 7 shared papers, 2013–2025 · strength 0.80
  2. Daniele Campa · 7 shared papers, 2013–2025 · strength 0.63
  3. Cosmeri Rizzato · 6 shared papers, 2013–2025 · strength 0.53
  4. Stefano Landi · 5 shared papers, 2013–2025 · strength 0.32
  5. Manuel Gentiluomo · 2 shared papers, 2022–2025 · strength 0.31
  6. Lívia Archibugi · 2 shared papers, 2022–2025 · strength 0.30
  7. Giulia Peduzzi · 2 shared papers, 2022–2025 · strength 0.30
  8. David J. Hughes · 2 shared papers, 2017–2025 · strength 0.24
  9. Kari Hemminki · 1 shared paper, 2025 · strength 0.22
  10. Božena Smolková · 1 shared paper, 2025 · strength 0.22
  11. Saba Selvi · 1 shared paper, 2025 · strength 0.22
  12. Erika Halášová · 1 shared paper, 2025 · strength 0.22
  13. Federico Canzian · 5 shared papers, 2013–2022 · strength 0.21
  14. Renata Talar‐Wojnarowska · 5 shared papers, 2013–2022 · strength 0.21
  15. Gabriele Capurso · 5 shared papers, 2013–2022 · strength 0.21
  16. Pavel Souček · 5 shared papers, 2013–2022 · strength 0.21
  17. Raffaele Pezzilli · 5 shared papers, 2013–2022 · strength 0.21
  18. Neil Daniel · 1 shared paper, 2025 · strength 0.20
  19. Annalisa Comandatore · 1 shared paper, 2025 · strength 0.20
  20. Riccardo Farinella · 1 shared paper, 2025 · strength 0.20
  21. Ruggero Ponz de Leon Pisani · 1 shared paper, 2025 · strength 0.20
  22. Pinar Uysal Onganer · 1 shared paper, 2025 · strength 0.20
  23. Juan Sáinz · 1 shared paper, 2025 · strength 0.20
  24. Beatrice Mohelníková-Duchoňová · 4 shared papers, 2013–2022 · strength 0.19
  25. Maria Gazouli · 4 shared papers, 2013–2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.